ACBDTAfrica Cancer BiomarkersDatabase & TechnologyContribute data
Evidence records
See the finding.
See how far it has been reviewed.
Each result exposes its cohort geography, assay, clinical role, and review state. Synthetic fixtures remain clearly marked until reviewer-approved evidence is published.
Discovery workspace
Start with a marker.
Follow the evidence chain.
Search synthetic pilot fixtures by biomarker, cancer, country, entity type, clinical role, and review state.
Refine results
Offline fallbackThe evidence API is temporarily unavailable. Local synthetic fixtures are shown so the prototype remains usable.
| Review state | Open record | ||||||
|---|---|---|---|---|---|---|---|
| Protein | Liver cancer | NigerWestern Africa | Diagnostic | 2023 | Unscreened | ||
| Gene | Breast cancer | TogoWestern Africa | Risk | 2022 | Unscreened | ||
| Protein | Breast cancer | GhanaWestern Africa | Predictive | 2023 | Cohort verified | ||
| Assay panel | Cervical cancer | GhanaWestern Africa | Diagnostic | 2024 | Unscreened | ||
| Viral DNA | Cervical cancer | NigeriaWestern Africa | Risk | 2024 | Requires full text | ||
| Protein | Breast cancer | NigeriaWestern Africa | Prognostic | 2019 | Cohort verified |